Mayor Greg Stanton served nine years on the Phoenix City Council. He was a leader in building a more diverse, sustainable economy, and a passionate supporter of education in our city.
Stanton has lived in Phoenix for 37 years. He grew up in west Phoenix and attended Cortez High School. His parents, Fred and Mary Ann, still live in the same house where he and his three siblings grew up.

After high school, Greg attended college at Marquette University and then law school at the University of Michigan. After completing his studies, he returned to his hometown of Phoenix. While maintaining a busy law practice, Greg always made community service a priority. In 2000, he was appointed to the Phoenix City Council. In 2001 and again in 2005, he won re-election with an overwhelming majority of the vote. While on the council he represented Phoenix District 6, which includes the Biltmore, Ahwatukee Foothills, Arcadia and North Central communities.

He was elected Mayor in November 2011, and started serving in January 2012.

Dr. John Carpten earned his Ph.D. in Molecular, Cellular, and Developmental Biology at the Ohio State University in 1994 with a focus on human genome physical mapping and positional candidate cloning.  He then went on to complete a postdoctoral fellowship at the National Human Genome Research Institute, NIH, Bethesda, in Cancer Genetics, where he was later promoted to the tenure track in 2000. Dr. Carpten then accepted a position to become Division Director at the Translational Genomics Research Institute (TGen), Phoenix, AZ, in 2003 where he currently directs the Division of Integrated Cancer Genomics.  In 2012 he was promoted to the position of Deputy Director of Basic Research for TGen.

Dr. Carpten’s research program centers around the development and application of cutting edge genomic technologies and bioinformatics analysis in search of germ-line and somatic alterations that are associated with risk and tumor characteristics, respectively.  He has led and co-authored a series articles describing the roles of both low and high penetrant genetic variants in cancer risk in Science, Nature, Nature Genetics, Genome Research, and New England Journal of Medicine.

To improve the discovery of important alterations associated with cancer, Dr. Carpten is co-leading the implementation, development, and application of Next Generation Sequencing (NGS) technologies at TGen.  These technologies offer the opportunity to comprehensively interrogate cancer genomes to uncover the lexicon of somatic events within a tumor.  Currently, the largest efforts of the Carpten laboratory are in applying NGS for Genomics Enabled Medicine, where cancer genomes and transcriptomes are sequenced and used to identify targetable events for select therapeutics.  Furthermore, he is helping to drive efforts to build CLIA capabilities within TGen to support these efforts. It is his hope that this work will one day lead to improvements in knowledge based therapeutics toward improvements in outcomes for cancer patients.

As Vice President of Clinical and Support Services for Cancer Treatment Centers of America (CTCA) at Western Regional Medical Center, Susan Zook is responsible for the Radiation Oncology, Imaging Services, Cardiopulmonary Services and Medical Laboratory Departments’ operations and financial performance.

Ms. Zook has been with CTCA since 2005. She originally joined the organization as the Director of Imaging Services at CTCA at Southwestern Regional Medical Center in Tulsa, Oklahoma. Ms. Zook joined the CTCA team in Phoenix in April 2008. She was responsible for all clinical capital equipment negotiation, acquisition and installation. Additionally, she served as a clinical consultant during construction of the hospital.

Ms. Zook graduated from the University of Oklahoma with a bachelor’s degree in radiation sciences. She is a registered radiologic technologist, registered mammographer and a certified breast exam instructor.

She is a member of the American College of Healthcare Executives, American Hospital Radiology Administrators, American Society for Radiation Oncology and the Radiological Society of North America. Ms. Zook volunteers her time for a variety of professional organizations including the Radiologic Technology Program Advisory Board, MedAssets’ National Radiology Advisory Board and International Capital and Management Company’s Board of Managers. Ms. Zook is a lecturer at the American Society of Radiologic Technology’s state meetings, where her dynamic lectures on breast imaging and pathology, patient privacy and confidentiality and customer service in the healthcare setting are always sold out